Adrienne L. Graves
CIK: 0001326192
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 18, 2026HROW
HARROW, INC.
Award(A)DirectRSU
5.2K shares- - Jun 10, 2026OCUL
OCULAR THERAPEUTIX, INC
Award(A)Direct14K shares- - May 18, 2026HROW
HARROW, INC.
Purchase(P)Direct1K shares at avg. $31.07$31K - Apr 20, 2026IRD
Opus Genetics, Inc.
Award(A)Direct24.4K shares- - Jan 1, 2026IRD
Opus Genetics, Inc.
Award(A)Direct23.6K shares- - Jun 20, 2025HROW
HARROW, INC.
Award(A)DirectRSU
7.3K shares- - Jun 11, 2025OCUL
OCULAR THERAPEUTIX, INC
Award(A)Direct14K shares- - Apr 30, 2025IRD
Opus Genetics, Inc.
Award(A)Direct79.5K shares- - Oct 22, 2024IRD
Opus Genetics, Inc.
Award(A)DirectStock Option (right to buy)
172.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  HROW HARROW, INC. | Award(A) RSU | 5,248 | - | - | Direct |
| Jun 10, 2026 |  OCUL OCULAR THERAPEUTIX, INC | Award(A) | 14,000 | - | $0 | Direct |
| May 18, 2026 | HROW HARROW, INC. | Purchase(P) | 1,000 | $31.07 | $31,070 | Direct |
| Apr 20, 2026 |  IRD Opus Genetics, Inc. | Award(A) | 24,367 | - | $0 | Direct |
| Jan 1, 2026 | IRD Opus Genetics, Inc. | Award(A) | 23,643 | - | $0 | Direct |
| Jun 20, 2025 | HROW HARROW, INC. | Award(A) RSU | 7,339 | - | - | Direct |
| Jun 11, 2025 | OCUL OCULAR THERAPEUTIX, INC | Award(A) | 14,000 | - | - | Direct |
| Apr 30, 2025 | IRD Opus Genetics, Inc. | Award(A) | 79,504 | - | - | Direct |
| Oct 22, 2024 | IRD Opus Genetics, Inc. | Award(A) Stock Option (right to buy) | 172,874 | - | - | Direct |
1-9 of 9 transactions
About Graves Adrienne L
Graves Adrienne L (SEC CIK 0001326192) files insider reports with the SEC as Director of HARROW, INC. (HROW), Director of OCULAR THERAPEUTIX, INC (OCUL) and Director of Opus Genetics, Inc. (IRD).
Signal8 holds 10 ownership filings by Graves Adrienne L (1 Form 3, 9 Form 4), filed between Oct 24, 2024 and Jun 22, 2026. Those filings report 9 transactions, from Oct 22, 2024 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Graves Adrienne L's filings is in BEDFORD, MA.
Recent filings by Graves Adrienne L
- Jun 18, 2026: Grant or award of HROW derivative securities (Form 4, code A).
- Jun 10, 2026: Grant or award of OCUL shares (Form 4, code A).
- May 18, 2026: Open-market purchase of HROW shares (Form 4, code P).
- Apr 20, 2026: Grant or award of IRD shares (Form 4, code A).
- Jan 1, 2026: Grant or award of IRD shares (Form 4, code A).
Other insiders filing for HARROW, INC. (HROW)
- Shojaei Amir, CHIEF SCIENTIFIC OFFICER
- Sternberg Perry J., Director
- SILVERNAIL LAUREN P, Director
- BAUM MARK L, CHIEF EXECUTIVE OFFICER
- BOLL ANDREW R., PRESIDENT AND CFO
- Opaleye Management Inc., 10% Owner